Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 64 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1302. Clear
Clear
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q2
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $220,000.00 income
Copyright/Patent/Trademark, Health Issues
View → Q2
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
S-3 GROUP for VIATRIS (MYLAN, INC)
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q2
HOLLAND & KNIGHT LLP for VIATRIS INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy
View → Q1
VIATRIS INC. for VIATRIS INC
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate
Health Issues, Copyright/Patent/Trademark, Trade (domestic/foreign), Financial Institutions/Investments/Securities
View → 1A
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues
View → Q1
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Health Issues
View → Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View → RR
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania
Health Issues
View → Q1
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $60,000.00 income
Pharmacy
View → Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q1
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Previous Page 3 of 3

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem